{"title":"钠-葡萄糖共转运蛋白2抑制剂降低肾结石发生率的药理作用","authors":"Arash Najafian, Sadaf Esteki","doi":"10.34172/jpd.2023.11220","DOIUrl":null,"url":null,"abstract":"Nephrolithiasis is one of the common diseases without effective treatment, the incidence of which has increased in the world in recent decades. Sodium-glucose co-transporter 2 inhibitor can reduce the probability of nephrolithiasis in diabetic and non-diabetic people.","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"150 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pharmacological effect of sodium-glucose cotransporter 2 inhibitors in reducing the incidence of nephrolithiasis\",\"authors\":\"Arash Najafian, Sadaf Esteki\",\"doi\":\"10.34172/jpd.2023.11220\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Nephrolithiasis is one of the common diseases without effective treatment, the incidence of which has increased in the world in recent decades. Sodium-glucose co-transporter 2 inhibitor can reduce the probability of nephrolithiasis in diabetic and non-diabetic people.\",\"PeriodicalId\":16657,\"journal\":{\"name\":\"Journal of Parathyroid Disease\",\"volume\":\"150 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Parathyroid Disease\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.34172/jpd.2023.11220\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Parathyroid Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/jpd.2023.11220","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Pharmacological effect of sodium-glucose cotransporter 2 inhibitors in reducing the incidence of nephrolithiasis
Nephrolithiasis is one of the common diseases without effective treatment, the incidence of which has increased in the world in recent decades. Sodium-glucose co-transporter 2 inhibitor can reduce the probability of nephrolithiasis in diabetic and non-diabetic people.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
